Paper31392205
The role of patient advocacy organizations in shaping medical research: the Pompe model.
House T and 6 others. Ann Transl Med, 2019. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The role of patient advocacy organizations in shaping medical research: the Pompe model. Papers, record 31392205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31392205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26685070 | Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes. | J Pediatr | 2016 | https://conductscience.org/library/papers/26685070 | PubMed |
| 2 | 26768149 | Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study. | J Inherit Metab Dis | 2016 | https://conductscience.org/library/papers/26768149 | PubMed |
| 3 | 18519449 | Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. | Pediatrics | 2008 | https://conductscience.org/library/papers/18519449 | PubMed |
| 4 | 23632029 | Pompe disease: early diagnosis and early treatment make a difference. | Pediatr Neonatol | 2013 | https://conductscience.org/library/papers/23632029 | PubMed |
| 5 | 25617983 | Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease. | Neuromuscul Disord | 2015 | https://conductscience.org/library/papers/25617983 | PubMed |
| 6 | 29155436 | Enzyme replacement therapy for infantile-onset Pompe disease. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29155436 | PubMed |
| 7 | 24243590 | A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment. | Am J Med Genet A | 2014 | https://conductscience.org/library/papers/24243590 | PubMed |
| 8 | 20404746 | Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease. | J Neuroophthalmol | 2010 | https://conductscience.org/library/papers/20404746 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41332486 | Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study. | Risk Manag Healthc Policy | 2025 | https://conductscience.org/library/papers/41332486 | PubMed |
| 39253288 | Global hepatitis B and D community advisory board: expectations, challenges, and lessons learned. | Front Public Health | 2024 | https://conductscience.org/library/papers/39253288 | PubMed |
| 38987844 | A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem. | Orphanet J Rare Dis | 2024 | https://conductscience.org/library/papers/38987844 | PubMed |
| 38108236 | Building advocacy into research. | Dis Model Mech | 2023 | https://conductscience.org/library/papers/38108236 | PubMed |
| 34721018 | Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34721018 | PubMed |
| 33073001 | Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective. | Int J Neonatal Screen | 2020 | https://conductscience.org/library/papers/33073001 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31392205
GET https://conductscience.org/api/papers/v1/31392205/authors